Immunotherapy and Chemotherapy Shrink Peritoneal Mesothelioma Tumors: New Case Reports
Two new case reports appear to support the idea that immunotherapy and chemotherapy can work together to fight peritoneal mesothelioma. …
Chemotherapy | Europe | International | Surgery | Treatments
HITOC for Mesothelioma: Benefits May Outweigh the Risk
The benefits of a localized chemotherapy regimen known as HITOC for mesothelioma outweigh the small risk of kidney failure for…
Immune Checkpoint Inhibitor Safe Both Before and After Mesothelioma Surgery
A report presented to an international gathering of lung cancer doctors shows an immune checkpoint inhibitor can make pre-surgery chemotherapy…
Study Reveals How TTFields and Chemotherapy Fight Mesothelioma
TTFields and chemotherapy offer one of the most potent combinations against malignant mesothelioma tumors. Now a new study reveals why…
Neoadjuvant Chemotherapy Plus Surgery for Pleural Mesothelioma: A Prospective Study
A new prospective Japanese mesothelioma study shows the potentially life-saving benefits of undergoing neoadjuvant chemotherapy followed by surgery. This has…
Academic Medical Centers Extend Peritoneal Mesothelioma Survival
A new published study suggests that peritoneal mesothelioma patients treated at academic medical centers survive much longer than those who…
Chemotherapy | Europe | International | Surgery | Treatments
New Study: PD Surgery and HITHOC for Pleural Mesothelioma
German doctors say a combination of extended PD surgery and HITHOC has produced some ‘remarkable’ results for patients with pleural…
Comparing Second-Line Therapies for Recurrent Mesothelioma
University of Pennsylvania researchers have some hopeful news for people with recurrent mesothelioma after chemotherapy: Second-line immunotherapy might increase their…
Chemotherapy | Europe | International | New Studies | Research | Treatments
Treatment with Vinorelbine for Relapsed Pleural Mesothelioma
A new study suggests that treatment with vinorelbine may boost progression free survival for people with relapsed malignant mesothelioma. Mesothelioma…
Inflammation Protein May Impact Drug Therapies for Mesothelioma
A protein involved in the inflammatory process could impact how patients respond to drug therapies for mesothelioma. The news comes…